Agenus Provides Corporate Update and First Quarter 2023 Financial Results

Author's Avatar
May 09, 2023

Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company with an extensive pipeline of clinical and preclinical-stage cancer treatments, today provided a corporate update and reported financial results for the first quarter 2023.